Red Wine, White Wine Improve Cardiometabolic Risk Markers in Diabetics, says a 2-Year Trial

Alcohol Intake and Associated Risk of Major Cardiovascular Outcomes in Women Compared With Men
12 March, 2016
Medical Error Is Third Leading Cause of Death in US
12 March, 2016

Red Wine, White Wine Improve Cardiometabolic Risk Markers in Diabetics, says a 2-Year Trial


A glass of wine with dinner can improve lipid and glycemic control profiles in patients with type 2 diabetes mellitus, suggests a small trial. Findings from the Cardiovascular Diabetes and Ethanol trial, which included 224 patients from two centers in Israel with controlled diabetes, showed that those who consumed 150 mL/day of red wine plus a Mediterranean diet had significantly higher levels of (good) cholesterol after 2 years compared with those who drank equal amounts of mineral water plus the healthy diet (the primary outcomes).

In addition, the group randomized to white wine intake had significantly decreased fasting plasma glucose levels vs the mineral-water group. Both wine groups also had significantly improved triglyceride levels. “But for now, the results suggest modest beneficial effects of initiating moderate wine consumption, and red wine in particular” for this patient group, said the researcher. However, “these benefits should be weighed against potential risks when translated into clinical practice.”

Leave a Reply

Your email address will not be published. Required fields are marked *

This website uses own and third-party cookies. If you continue to browse the site, you are agreeing to the use of cookies. More info about the Cookie Policy.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.